Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · IEX Real-Time Price · USD
6.29
-0.15 (-2.33%)
May 2, 2024, 11:15 AM EDT - Market open

Lifecore Biomedical Revenue

In the fiscal year ending May 28, 2023, Lifecore Biomedical had annual revenue of $103.27M, a decrease of -7.19%. Revenue in the quarter ending May 28, 2023 was $25.52M with 20.78% year-over-year growth.

Revenue (ttm)
$103.27M
Revenue Growth
-7.19%
P/S Ratio
1.90
Revenue / Employee
$224,987
Employees
459
Market Cap
190.61M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
May 28, 2023103.27M-8.00M-7.19%
May 29, 2022111.27M10.40M10.31%
May 30, 2021100.87M-59.19M-36.98%
May 31, 2020160.07M-397.49M-71.29%
May 26, 2019557.56M33.33M6.36%
May 27, 2018524.23M54.45M11.59%
May 28, 2017469.78M-7.14M-1.50%
May 29, 2016476.92M-62.34M-11.56%
May 31, 2015539.26M62.44M13.10%
May 25, 2014476.81M35.11M7.95%
May 26, 2013441.71M124.16M39.10%
May 27, 2012317.55M40.82M14.75%
May 29, 2011276.73M38.51M16.16%
May 30, 2010238.22M2.29M0.97%
May 31, 2009235.94M-2.59M-1.09%
May 25, 2008238.53M28.03M13.32%
May 27, 2007210.50M-21.46M-9.25%
May 28, 2006231.95M26.72M13.02%
May 29, 2005205.23M13.14M6.84%
May 30, 2004192.09M8.94M4.88%
Oct 27, 2002183.16M-7.49M-3.93%
Oct 28, 2001190.65M-6.58M-3.34%
Oct 29, 2000197.23M175.78M819.64%
Oct 31, 199921.45M-12.07M-36.01%
Oct 31, 199833.52M24.00M252.21%
Oct 31, 19979.52M7.45M360.38%
Oct 31, 19962.07M-1.39M-40.26%
Oct 31, 19953.46M1.76M103.53%
Oct 31, 19941.70M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
G1 Therapeutics 82.51M
Alimera Sciences 80.75M
Innate Pharma 68.49M
Zevra Therapeutics 27.46M
Century Therapeutics 2.24M
Cardiff Oncology 488.00K
Revenue Rankings

LFCR News

More News